BAMF
AMPH icon

BI Asset Management Fondsmaeglerselskab’s Amphastar Pharmaceuticals AMPH Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,359
Closed -$39K – 750
2025
Q1 		$39K Buy
+1,359
New +$43.4K ﹤0.01% 847
2024
Q2 		– Sell
-12,455
Closed -$547K – 638
2024
Q1 		$547K Buy
12,455
+4,811
+63% +$248K 0.01% 508
2023
Q4 		$473K Buy
+7,644
New +$402K 0.01% 534

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's AMPH Position: Q2 2025 in Review

BI Asset Management Fondsmaeglerselskab sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2025, closing a stake of 1,359 shares — an estimated $39K sold.

BI Asset Management Fondsmaeglerselskab first reported a position in AMPH in Q4 2023 and held it in 3 quarters. The position peaked at $547K in Q1 2024. 245 funds tracked by Wall St. Rank hold AMPH as of Q2 2025.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Amphastar Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 1,359 Amphastar Pharmaceuticals shares in Q2 2025, an estimated $39K.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Amphastar Pharmaceuticals in Q4 2023 and held it in 3 quarters.
  • BI Asset Management Fondsmaeglerselskab's Amphastar Pharmaceuticals position peaked at $547K in Q1 2024.
  • 245 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2025.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2025, filed 14 Aug 2025.